Company intelligence / Profile preview

h2o Therapeutics

Ankara, Turkey

Ownership: Private
Development stage: Other

Overview

h2o Therapeutics develops FDA-regulated digital therapeutics and software as a medical device, including Parky, a prescription Apple Watch–based app with 510(k) FDA clearance for monitoring tremor and dyskinesia in adults with Parkinson's disease, and Foggy, an Apple Watch freezing-of-gait cueing feature listed as a Class II medical device and available by prescription[2][5]. They also developed Covie, an early‑detection COVID‑19 smartwatch system[5].

Therapeutic areas: NeurologyInfectious Diseases
Modalities: DeviceNon-pharmacological therapySoftware as a medical device
Industry: Digital Health Medical Devices

Partnerships

AmerisourceBergen (commercialization and health system integration for Parky via DTx Connect platform)[2][5]

Beyond the preview

Go deeper on h2o Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on h2o Therapeutics.

Explore the full profile